MedLensLoading…
Generic name: amoxicillin and clavulanate potassium
Drops · Zoetis Inc.
Dosage Form
Drops
Manufacturer
Zoetis Inc.
This medication contains important usage instructions, warnings, and side effect information that you should review before use.
Dogs: The recommended dosage is 6.25 mg/lb (1 mL/10 lb) of body weight twice a day. Skin and soft tissue infections such as abscesses, cellulitis, wounds, superficial/juvenile pyoderma, and periodontal infections should be treated for 5–7 days or for 48 hours after all symptoms have subsided. If no response is seen after 5 days of treatment, therapy should be discontinued and the case reevaluated. Deep pyoderma may require treatment for 21 days; the maximum duration of treatment should not exceed 30 days.
Cats: The recommended dosage is 62.5 mg (1 mL) twice a day. Skin and soft tissue infections such as abscesses and cellulitis/dermatitis should be treated for 5–7 days or 48 hours after all symptoms have subsided, not to exceed 30 days. If no response is seen after 3 days of treatment, therapy should be discontinued and the case reevaluated.
Urinary tract infections may require treatment for 10–14 days or longer. The maximum duration of treatment should not exceed 30 days.
The use of this drug is contraindicated in animals with a history of an allergic reaction to any of the penicillins or cephalosporins.
Clavamox contains a semisynthetic penicillin (amoxicillin) and has the potential for producing allergic reactions.
If an allergic reaction occurs, administer epinephrine and/or steroids.
Clavamox (amoxicillin trihydrate/clavulanate potassium), USP is an orally administered formulation comprised of the broad-spectrum antibiotic Amoxi® (amoxicillin trihydrate) and the β-lactamase inhibitor, clavulanate potassium (the potassium salt of clavulanic acid).
Amoxicillin trihydrate is a semisynthetic antibiotic with a broad spectrum of bactericidal activity against many gram-positive and gram-negative, aerobic and anaerobic microorganisms. It does not resist destruction by β-lactamases; therefore, it is not effective against β-lactamase-producing bacteria. Chemically, it is D(-)-α-amino-p-hydroxybenzyl penicillin trihydrate.
Clavulanic acid, an inhibitor of β-lactamase enzymes, is produced by the fermentation of Streptomyces clavuligerus. Clavulanic acid by itself has only weak antibacterial activity. Chemically, clavulanate potassium is potassium z-(3R,5R)-2-β-hydroxyethylidene clavam-3-carboxylate.
CLAVAMOX®
(amoxicillin and clavulanate potassium for oral suspension), USP
Drops
For veterinary oral suspension
For use in dogs and cats
When reconstituted each mL contains 50 mg of amoxicillin USP as the trihydrate and 12.5 mg of clavulanic acid USP as the potassium salt.
Do Not Use if Product is Discolored
Caution: Federal law restricts this
drug to use by or on the order
of a licensed veterinarian.
15 mL
Approved by FDA under NADA # 055-101
zoetis
[image: MM1]Clavamox Drops are supplied in 15-mL bottles containing 50 mg of amoxicillin/12.5 mg of clavulanic acid per mL.
Photos of the product and/or packaging supplied by the manufacturer.
CLAVAMOX®
(amoxicillin and clavulanate potassium for oral suspension), USP
Drops
For veterinary oral suspension
For use in dogs and cats
Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
Clavamox is stable in the presence of gastric acid and is not significantly influenced by gastric or intestinal contents. The 2 components are rapidly absorbed resulting in amoxicillin and clavulanic acid concentrations in serum, urine, and tissues similar to those produced when each is administered alone.
Amoxicillin and clavulanic acid diffuse readily into most body tissues and fluids with the exception of brain and spinal fluid, which amoxicillin penetrates adequately when meninges are inflamed. Most of the amoxicillin is excreted unchanged in the urine. Clavulanic acid's penetration into spinal fluid is unknown at this time. Approximately 15% of the administered dose of clavulanic acid is excreted in the urine within the first 6 hours.
Clavamox combines the distinctive properties of a broad-spectrum antibiotic and a β-lactamase inhibitor to effectively extend the antibacterial spectrum of amoxicillin to include β-lactamase-producing as well as non-β-lactamase-producing aerobic and anaerobic organisms.
The recommended quantitative disc susceptibility method (FEDERAL REGISTER 37:20527–29; Bauer AW, Kirby WMM, Sherris JC, et al: Antibiotic susceptibility testing by standardized single disc method. Am J Clin Path 45:493, 1966) utilized 30 mcg Augmentin® (AMC) discs for estimating the susceptibility of bacteria to Clavamox Tablets and Drops.
Add 14 mL of water to the 15-mL bottle and shake vigorously. Each mL of suspension will contain 50 mg of amoxicillin activity as the trihydrate and 12.5 mg of clavulanic acid activity as the potassium salt.
Note: Any unused portion of the reconstituted suspension must be discarded after 10 days. Refrigeration of the reconstituted suspension is required.
Approved by FDA under NADA # 055-101
Clavamox is a trademark owned by and used under license from GlaxoSmithKline.
Augmentin is a trademark owned by GlaxoSmithKline.
zoetis
Distributed by:
Zoetis Inc.
Kalamazoo, MI 49007
Revised: February 2019
P1518388
Create a free account to view complete drug information, save medications, and more.
Free forever · No credit card required